Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs
Authors
Keywords
-
Journal
ACTA NEUROLOGICA SCANDINAVICA
Volume 134, Issue 1, Pages 54-60
Publisher
Wiley
Online
2015-10-13
DOI
10.1111/ane.12511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroprotective action of resveratrol
- (2015) Stéphane Bastianetto et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke
- (2015) Ping Zhuang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
- (2015) Tudor G. Jovin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resveratrol Attenuates the Blood-Brain Barrier Dysfunction by Regulation of the MMP-9/TIMP-1 Balance after Cerebral Ischemia Reperfusion in Rats
- (2014) Haidong Wei et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Resveratrol Attenuates Early Brain Injury After Subarachnoid Hemorrhage Through Inhibition of NF-κB-Dependent Inflammatory/MMP-9 Pathway
- (2013) An-Wen Shao et al. CNS Neuroscience & Therapeutics
- Neuroprotective Effect of Resveratrol on Ischemia/Reperfusion Injury in Rats Through TRPC6/CREB Pathways
- (2013) Yun Lin et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats
- (2013) Prabhakar Orsu et al. JOURNAL OF NEURAL TRANSMISSION
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
- (2013) Valery L Feigin et al. LANCET
- Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA)
- (2012) A. Eissa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Protection against Recurrent Stroke with Resveratrol: Endothelial Protection
- (2012) Darren Clark et al. PLoS One
- The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria
- (2011) Peter Chudý et al. BLOOD COAGULATION & FIBRINOLYSIS
- Improving reperfusion therapy for acute ischaemic stroke
- (2011) J. L. SAVER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
- (2010) Anna Morancho et al. Annals of the New York Academy of Sciences
- Dose-Dependency of Resveratrol in Providing Health Benefits
- (2010) Subhendu Mukherjee et al. Dose-Response
- Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients
- (2010) Kazuomi Kario et al. EUROPEAN HEART JOURNAL
- Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation
- (2010) Jing-Bo Zhang et al. NEUROLOGICAL RESEARCH
- Dissociation and Protection of the Neurovascular Unit after Thrombolysis and Reperfusion in Ischemic Rat Brain
- (2009) Toru Yamashita et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Combination Therapy of 17 -Estradiol and Recombinant Tissue Plasminogen Activator for Experimental Ischemic Stroke
- (2009) R. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
- (2008) Rao Adibhatla et al. CNS & Neurological Disorders-Drug Targets
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now